PMID: 7036801Jan 1, 1982Paper

Double-blind controlled clinical trial of ancrod for ischemic rest pain of the leg

Angiology
G D LoweM M Drummond

Abstract

In a randomized double-blind trial, patients with ischemic rest pain of the leg received 8 days of treatment with intravenous injections of the defibrinating agent, ancrod (Arvin) or saline. Plasma fibrinogen, plasma viscosity, and blood viscosity were significantly reduced during ancrod therapy. After 27 patients had completed treatment, sequential analysis showed no preference for either therapy. In each group two-thirds of the patients claimed improvement in pain after treatment. There were no significant differences between treatment groups in analgesic consumption, Doppler systolic pressure ratio, or surgical intervention in the 6 months following treatment. We conclude that in patients with ischemic rest pain, ancrod therapy is not superior to placebo injections, and that the effect of placebo treatment is considerable.

Citations

Jan 1, 1985·Pharmacology & Therapeutics·F Kornalík
Dec 1, 1986·Journal of the American College of Cardiology·H BounameauxM Verstraete
Sep 1, 1987·Baillière's Clinical Haematology·G D Lowe
Oct 1, 1990·European Journal of Vascular Surgery·L Norgren
Jun 10, 2005·Journal of Vascular Surgery·Girma TeferaWilliam D Turnipseed
Apr 2, 2003·Vascular and Endovascular Surgery·Girma TeferaTimothy Tanke
Nov 1, 2000·Der Internist·C DiehmW Theiss
Jun 5, 2019·Journal of Vascular Surgery·Michael S ConteUNKNOWN GVG Writing Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.